AIDS-related mycoses: the way forward

Gordon D Brown, Graeme Meintjes, Jay K Kolls, Clive Gray, William Horsnell, Working Group from the EMBO-AIDS Related Mycoses Workshop

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)


The contribution of fungal infections to the morbidity and mortality of HIV-infected individuals is largely unrecognized. A recent meeting highlighted several priorities that need to be urgently addressed, including improved epidemiological surveillance, increased availability of existing diagnostics and drugs, more training in the field of medical mycology, and better funding for research and provision of treatment, particularly in developing countries.

Original languageEnglish
Pages (from-to)107-109
Number of pages3
JournalTrends in Microbiology
Issue number3
Early online date26 Feb 2014
Publication statusPublished - Mar 2014

Bibliographical note

Copyright © 2014 Elsevier Ltd. All rights reserved.

We thank the following for their support of the workshop held in Cape Town in July 2013: Associates of Cape Cod, Cepheid, Clinical Infectious Diseases Research Initiative, Company of Biologists, Department of Science and Technology (Republic of South Africa), Elsevier, European Molecular Biology Organization (EMBO), Fungal Infection Trust, Gilead, Immuno-Mycologics, International Society for Human and Animal Mycology, Merck Sharp & Dohme (MSD), Miravista Diagnostics, National Research Foundation of South Africa, South African Immunology Society, Scientific Group, University of Cape Town, Wellcome Trust, and Zeiss.


  • HIV
  • AIDS
  • fungal infection
  • mortality
  • translational research
  • immunity


Dive into the research topics of 'AIDS-related mycoses: the way forward'. Together they form a unique fingerprint.

Cite this